share_log
Reuters ·  May 7 09:35
Eli Lilly: FDA to Convene in-Person Meeting of Peripheral & Central Nervous System Drugs Advisory Committee (Pcns) on June 10, to Discuss Donanemab
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment